Picture of Aarti Drugs logo

AARTIDRUGS Aarti Drugs Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

C2021
March 31st
2022
March 31st
R2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,6902,7002,2422,3552,118
Depreciation
Non-Cash Items187204348316286
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2,827-2,707-1,760404-515
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities1,5506961,3333,5892,446
Capital Expenditures-882-1,520-1,648-2,263-1,772
Purchase of Fixed Assets
Other Investing Cash Flow Items16531.18.4626.8125
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-718-1,489-1,640-2,237-1,646
Financing Cash Flow Items-230-344-362-446-468
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-811920165-1,360-821
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash20.4128-141-7.61-21.7